Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9851 USD | +2.61% | -7.07% | -6.18% |
Apr. 01 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 26 | Transcript : Quince Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-6.18% | 42.57M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- QNCX Stock
- News Quince Therapeutics, Inc.
- Cortexyme : HC Wainwright Adjusts Cortexyme's Price Target to $200 From $76, Keeps Buy Rating